CORC  > 四川大学
ERRα suppression enhances the cytotoxicity of the MEK inhibitor trametinib against colon cancer cells
Sheng Zhou; Hongwei Xia; Huanji Xu; Qiulin Tang; Yongzhan Nie; Qi yong Gong; Feng Bi
刊名Journal of Experimental & Clinical Cancer Research
2018
卷号Vol.37 No.1页码:1-14
关键词Oestrogen-related receptor α (ERRα) Epidermal growth factor (EGF) Trametinib Simvastatin
ISSN号1756-9966
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/1823247
专题四川大学
作者单位Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University Laboratory of Molecular Targeted Therapy in Oncology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University Laboratory of Molecular Targeted Therapy in Oncology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University State Key Laboratory of Cancer Biology & Xijing Hospital of Digest Diseases, Fourth Military Medical University Department of Radiology, West China Hospital, Sichuan University Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University
推荐引用方式
GB/T 7714
Sheng Zhou,Hongwei Xia,Huanji Xu,et al. ERRα suppression enhances the cytotoxicity of the MEK inhibitor trametinib against colon cancer cells[J]. Journal of Experimental & Clinical Cancer Research,2018,Vol.37 No.1:1-14.
APA Sheng Zhou.,Hongwei Xia.,Huanji Xu.,Qiulin Tang.,Yongzhan Nie.,...&Feng Bi.(2018).ERRα suppression enhances the cytotoxicity of the MEK inhibitor trametinib against colon cancer cells.Journal of Experimental & Clinical Cancer Research,Vol.37 No.1,1-14.
MLA Sheng Zhou,et al."ERRα suppression enhances the cytotoxicity of the MEK inhibitor trametinib against colon cancer cells".Journal of Experimental & Clinical Cancer Research Vol.37 No.1(2018):1-14.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace